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Current approaches to pediatric heart catheterizations
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Abstract 
Sedation for pediatric cardiac catheteriza-
tion is a common requirement in many institu-
tions. As the field of cardiac catheterization
has evolved, the provision of sedation for these
procedures has been varied. Increasingly the
demand is for dedicated personnel focused on
monitoring and delivery of sedation while in
the catheterization suite. This article
describes the considerations one must use
when undertaking these cases. 
Introduction
Modern pediatric cardiac catheterization
began with in 1947 when Bing described using
catheterization for diagnosis of congenital
heart disease. In the ensuing period, echocar-
diography has become increasing refined and
has supplanted the need for many diagnostic
catheterizations. However, interventional
catheterizations have increasingly become a
mainstay of pediatric care. Pediatric interven-
tional catheterization began in earnest in 1968
with balloon atrial septostomy1 and quickly
became a common procedure in pediatric
catheterization. Numerous advances occurred
in the 1980s and 1990s. Modern pediatric car-
diac catheterization can now treat a number of
conditions including patent ductus arteriosus,
atrial septal defects, ventricular septal defects,
collateral vessels, valve stenosis, vessel steno-
sis, and conduction abnormalities. Increasing
minimally-invasive procedures has strained
the traditional model of anesthesia-directed
care in the operating room environment with a
variety of providers now administering analge-
sia and sedation for children.2 Pediatric heart
catheterizations have increased exponentially
in recent years.3 Sedation has traditionally
been under the direction of the performing
cardiologist. However, the need to have the
patient be motionless has increased as the
number of interventions has increased. In
addition, there is increased recognition that
dedicated personnel focused on monitoring of
the patient during sedation are associated
with improved safety. As the demand for seda-
tion outside of the operating room has
increased, a number of providers have gained
experience in providing for the sedation and
analgesia of these patients. In addition to a
number of different provider models, wide
variations exist in approaches to sedation reg-
imens.4 The different types of practitioners as
well as the special circumstances that accom-
pany congenital heart disease require special
emphasis.Composition of sedation team
A striking variety of practice models exist in
pediatric catheterization suites. Depending on
the practice setting, pediatric cardiologists,
registered nurses, Certified Registered Nurse
Anesthetist’s (CRNA), anesthesiologists, hos-
pitalists, pediatric emergency physicians, and
pediatric intensivists may perform the primary
role of sedation. Regardless of the provider, it
is essential that safe and effective sedation be
practiced. Debate continues for and against
non-anesthesiologists performing these seda-
tions.5-7 Regardless of the team composition,
consistency in NPO guidelines, monitoring,
and ability for resuscitation must be kept. The
reader is referred to excellent general guide-
lines available through the 2006 American
Academy of Pediatric Sedation Guidelines and
the 2002 American Society for Anesthesio -
logists Practice Guidelines for Sedation and
Analgesia by Non-Anesthesio logists.8,9Pre-procedural considerations
Prior to sedation, adequate consideration of
a patient’s physiologic status must be under-
taken. Important features include underlying
physiology, comorbidities and procedure to be
performed. Some cooperative patients (older
children and adults with congenital heart dis-
ease) may be able to have anxiolysis or light
sedation and achieve excellent outcomes.
Younger children will however require deep
sedation (minimal response to painful stim-
uli) at least initially. The goals of catheteriza-
tion must be reviewed (Table 1).Congenital heart disease
Patients with congenital heart lesions are a
common group of children undergoing pedi-
atric cardiac catheterization. Understanding of
the specific lesion and how hypotension, hypo-
or hypercarbia, and supplemental oxygen alter
the patient’s hemodynamics is critical. Volume
status changes and afterload alterations can
severely alter the physiology of both cyanotic
and acyanotic lesions.
Included in the preoperative checklist is a
review of the latest echocardiogram, hospital
history, and previous surgical procedures.
The authors strongly recommend that seda-
tion is undertaken only by practitioners inti-
mately familiar with the cardiovascular physi-
ology of these conditions. Choices such as sup-
plemental oxygen, assisted or mechanical ven-
tilation changes in acid-base status, and alter-
ations of systemic and pulmonary vascular
resistance will alter interpretation of diagnos-
tic data.Interventional catheterization
Interventional catheterizations require spe-
cial consideration. The technical nature of
these procedures demands minimal sponta-
neous movement. Many interventions are
more painful (e.g. aortic angioplasty) than a
diagnostic catheterization; requiring substan-
tially more attention to analgesic needs. In
addition, closure devices for atrial septal
defects and ventricular septal defects alter the
hemodynamics of the patient. Relatively high
complication rates are associated with closure
devices that alter sedation management.10,11
The practitioner must be able to rapidly
address cardiorespiratory changes in these
patients. As with all deep sedations, expertise
in airway management and intubation is a
must.12Radiofrequency ablation
The need for sedation has increased as
techniques for radiofrequency ablation have
advanced. Many of these children have con-
genital heart disease, in addition to managing
the arrhythmia-induced cardiovascular
changes that are prerequisite with these
patients. These patients also have longer pro-
cedure times than other candidates for proce-
dural sedation. Joung et al found that their
procedure times for atrial tachycardias aver-
aged 131.0±48.8 minutes. However, they also
found that the procedure time was reduced
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when the patient received sedation rather than
general anesthesia.13 Concerns that the seda-
tion or anesthesia regimen may alter the con-
duction pathways and invalidate the electro-
physiology study may be exaggerated.14,15Goals of catheterization
As with any procedure, the sedation tech-
nique will vary depending on the goal of the
procedure. For instance, in a diagnostic
catheterization to determine the degree of
reversible pulmonary vascular disease, multi-
ple variables would need to be considered.
Hypo- or hyperventilation, supplemental oxy-
gen, and acid-base status need to be manipu-
lated. Therapeutic agents that alter vascular
tone will ultimately alter the interpretation of
the study.16 The prodecuralists must communi-
cate their interventions with particular atten-
tion paid to the ramifications on the patient’s
hemodynamics. Sedation regimens
The ideal sedative agent does not exist.Demerol, Phenergan and Thorazine 
Traditionally, agents such as Demerol,
Phenergan, and Thorazine (DPT) have been
used in pediatric catheterizations. Benefits of
its use included oral or intramuscular adminis-
tration. However, variable efficacy and a
marked complication and side effect profile
have been documented. Other oral agents have
been documented to have superior efficacy to
DPT.17 In 2005, the American Academy of
Pediatrics retired its policy on DPT and instead
wrote Neither the combination itself nor its
dosage is based on sound pharmacologic data.
There is a high rate of therapeutic failure as
well as a high rate of serious adverse reactions,
including respiratory depression and death,
associated with its use. Even when it is effec-
tive, DPT appears to lack many of the desirable
characteristics of a sedative for children.
While many practitioners may have experi-
ence and expertise using this combination of
medications, this regimen is likely to have
greater complications and adverse effects than
other regimens. In 2004, a black box warning
was added to promethazine contraindicating
its use in children under 2 years of age second-
ary to the severe adverse-events, including
death. Most practitioners have discontinued
this practice.Midazolam
Midazolam is a short-acting benzodiazepine
with a large body of evidence in pediatric care.
Among the reason for midazolam’s popularity
is its ability to be given through a variety of
routes, including nasal administration.
Commercially, it is the most commonly used
pediatric premedication for generalized anes-
thesia.18 In the anesthetic setting, premedica-
tion with midazolam has no significant car-
diorespiratory effects.19 While an effective
anxiolytic in most children, a significant
minority of children have extreme distress
nonetheless.20
Midazolam has been successfully used as a
solo agent for pediatric catheterization. Jobier
et al. describe a cohort of 35 patients within a
group of 154 patients who received midazolam
0.14 mg/kg/hr intravenously without complica-
tions.21 Unfortunately in this study, there was
no criteria as to what criteria supported the
used of midazolam as an only agent.Ketamine
Ketamine is a hypnotic/sedative medication
preferred by many in pediatric catheterization
suites.22 Among its benefits is the ability to
protect airway reflexes with minimal effect on
respiration with preserved cardiac function.
Concerns regarding emergence reactions have
limited its usage. However, in a study by
Karapinar et al., emergence reactions occurred
in less than 2%. Some clinicians co-administer
midazolam to prevent these reactions; howev-
er, the efficacy of this practice has been debat-
ed.23
Although some tout ketamine as having
minimal hemodynamic effect, ketamine can
significantly alter catheterization data.22
Ketamine preserves cardiac function through
increased sympathetic effects. Whether keta-
mine increases pulmonary vascular resistance
remains to be elucidated.24 Some have seen
increases in systemic vascular resistance also.
For instance, ketamine is frequently used with
lesions such as aortic stenosis in which exces-
sive afterload reduction may be deleterious.
Other sedation regimens may be better suited
for other lesions, which cannot tolerate
increases in afterload, such as mitral regurgi-
tation.Propofol
The commercial availability of propofol in
1989 brought the ability to induce general
anesthesia outside of the confines of the oper-
ating room. Expensive inhaled anesthesia
machines and scavenger devices introduced
the concept of safari teams.25 In addition, non-
anesthesiologists became increasingly com-
fortable with this medication and propofol
services were introduced.26
It is important to note there are currently
three preparations of propofol approved for use
by the FDA. One of these preparations uses
benzyl alcohol as its emulsion agent. Infants
have had significant toxicity and even death as
a result of high doses given as a preservative.
Propofol has a number of properties that
make it advantageous over other sedation reg-
imens. It has many, but not all, of the proper-
ties of an ideal sedative drug. It has a pre-
dictable onset of action, a short half-life with a
rapid recovery time, and is easily titratable.
However, propofol is associated with profound
respiratory depression outside of a fairly nar-
row therapeutic window. Like all of the seda-
tive regimens listed here, propofol provides no
analgesic activity. In fact, there is some evi-
dence that propofol given in sub-anesthetic
doses induces hyperalgesia.27 In addition,
propofol induces clinically relevant changes in
cardiac index with decreases in afterload and
preload.28
Prolonged propofol sedation should not
occur in children. In 2001, the FDA issued a
black box warning which reported the results
of a study of 327 sedated patients in pediatric
intensive care units treated with either propo-
fol or standard sedative agents. In this unpub-
lished study, a significantly higher number of
patients died in the propofol arms of the study.
Many speculate that the increased incidence of
mortality may be due to propofol infusion syn-
drome. The syndrome, characterized by a pro-
found metabolic acidosis, rhabdomyolysis, and
ensuing death was first described in chil-
dren.29 The mechanism of action, thought to
be mitochondrial poisoning, has yet to be
elicited. In adults, recent reports show that
even short-term administration of propofol can
cause a metabolic acidosis.30 These findings
are also present in children undergoing car-
diac catheterization (unpublished data –
Turner). Some believe this acidosis may be an
early indication of propofol infusion syn-
Article
Table 1. Goals of catheterization.
1. Analgesia, anxiolysis, and amnesia for patient
2. Easy separation from parents at start of case 
3. Maintain airway and appropriate ventilation
4. Monitor and maintain appropriate acid-base status
5. Minimize cardiovascular stress on the patient 
6. Optimize hemodynamic status before, during, and after the procedure, tailored to the 
specific physiology of the individual patient
7. Immobilization for precision, particularly when interventions are needed
8. Smooth transition to awake state after procedure, minimizing cardiovascular stress upon 
awakening (avoiding/minimizing agitation, hypertension, coughing fits, tachycardia, etc)
9. Provide appropriate conditions for obtaining useful cath data (i.e. testing with nitric oxide, valsalva, 
spontaneous breathing vs positive pressure ventilation, etc) 
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drome.31
In the setting of pediatric catheterization,
propofol (usually in combination with an anal-
gesic) has been used with increasing frequen-
cy. In practice, PVR remains constant; while
SVR decreases.32 Diagnostic data needs to be
interpreted with this in mind as this does
decrease shunt ratios. In addition to patients
with cardiomyopathies, congenital cyanotic
heart lesions may be particularly susceptible to
deterioration.33Propofol and ketamine
In an effort to preserve SVR while retaining
the positive aspects of propofol (quick onset of
action, predictable response, rapid recovery
time), some practices have incorporated the
addition of ketamine infusions.34,35 Ketamine
and propofol have opposing influences on
blood pressure, heart rate, and SVR. In addi-
tion, ketamine supplementing a propofol infu-
sion has been shown to preserve respiratory
function and upper airway control in several
studies.34,36 Recovery times were 20 minutes
in a group of children given propofol at 25
ug/kg/min with the addition of ketamine at
12.5 ug/kg/minute.34Dexmedetomidine
Dexmedetomidine is a a2 agonist sedative
and mild analgesic approved by the FDA in
1999 which preserves cardiorespiratory func-
tion. It has similar actions to clonidine, anoth-
er a2 agonist. However, dexmedetomidine has
a short half-life elimination of 6 minutes and
terminal half-life of 2 hours. Although
approved for mechanically ventilated adults for
periods less than 24 hours, experience is
increasing in using this medication in chil-
dren. Over 2300 sedations have been reported
to the pediatric sedation research consortium
(Berkenbosch – unpublished data).
Munro et al sedated 20 children for cardiac
catheterization with dexmedetomidine.37
Patients were given 1 ug/kg loading dose over
10 minutes followed by an infusion of 1
ug/kg/hr. Of these 20 patients, 12 patients
required a bolus of propofol for movement,
increasing BIS values, or prior to stimulation.
The patients had stable hemodynamics
throughout. 
Tosun et al. compared the combination of
dexmedetomidine-ketamine to propofol-keta-
mine in 44 patients.38 Two regimens were
compared: 
1. dexmedetomidine 0.7 ug/kg loading dose
over 10 minutes followed by an infusion of 1
ug/kg/hr and ketamine 1mg /kg bolus with 1
mg/kg/hr infusion
2. propofol 1mg/kg bolus followed by an infu-
sion of 100 ug/kg/min and ketamine 1 mg
/kg bolus with 1mg/kg/hr infusion
In the Tosun study, patients on the
dexmedetomidine regimen required more sup-
plemental doses of ketamine for discomfort.
No differences in side effects were noted,
including hypotension. In addition, recovery
times were significantly longer (45 v. 20 min-
utes; P=0.01)
To date, no studies have been performed
which examine the effects of dexmedetomi-
dine alone or in combination with other seda-
tives on pediatric catheterization data includ-
ing SVR and shunt ratios.Etomidate
Etomidate is another medication, which has
recently fallen out of favor. Documentation of
adrenal axis suppression as well as painful
induction has decreased its usage in intensive
care settings. However, in some institutions,
its favorable hemodynamic profile has made it
a common medication among children with
reserved hemodynamic function. Sarkar et al.
examined the hemodynamic responses to 12
children undergoing pediatric cardiac
catheterization for ablation of superventricular
tachycarida or ASD closure. There were no sig-
nificant changes in hemodynamic profiles in
these children.39Analgesics
Control of pain is an essential component to
a well-performed sedation. The provision of
sedative agents does not provide for pain
relief. Some agents (e.g. propofol) have hyper-
gesic properties. This must be tempered with
the realization that the addition of opioid
agents may act synergistically other sedative
agents. Topical agents such as EMLA and LMX-
4 as well as subcutaneous local anesthetics
can dramatically decrease the need for sys-
temic agents. Many our patients require mini-
mal sedation following administration of local
lidocaine and catheter insertion. Some older
patients may tolerate a catheterization with
minimal sedation if their pain needs are cared
for.Special considerations
Regardless of the sedation regimen imple-
mented, pediatric cardiac patients have
unique characteristics that need to be
acknowledged. For example, the addition of
supplemental oxygen can dramatically alter
cardiac output, as well as alter the interpreta-
tion of catheterization data. Alterations in ven-
tilation with positive pressure, hypo- or hyper-
ventilation may alter pulmonary blood flow,
again leading to data that may be difficult to
interpret
Consideration must be taken into the length
of the procedure. Recent reports highlight the
potential deleterious effects of sedatives such
as ketamine, propofol, and midazolam on the
developing brain.40,41 As the length of the pro-
cedure increases, attention to metabolic sub-
strates (i.e. glucose), environmental stresses,
temperature regulation, and pulmonary toilet
must be addressed. Coordination of the seda-
tion procedurals with the cardiologist is a must
to ensuring optimal outcomes.
Post-sedation care is a continuation of the
procedure. Qualified personnel, trained in
resuscitation from deep sedation and general
anesthesia, as well as knowledgeable of con-
genital heart defects, should monitor these
patients until ready for ultimate disposition. 
Conclusions
Advances in pediatric catheterization have
increased the demand and complexity of
patients undergoing these procedures. This
patient population presents unique challenges
due to the large variability of their underlying
anatomy and physiology. Sedation regimens
are varied, with importance to the hemody-
namic profile of the patients. Dedicated seda-
tion teams are a necessary requirement to
optimal performing catheterization labs. 
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